US Stock MarketDetailed Quotes

ICCM Icecure Medical

Watchlist
  • 1.070
  • +0.130+13.83%
Close Dec 13 16:00 ET
  • 1.070
  • 0.0000.00%
Post 20:02 ET
59.39MMarket Cap-3.82P/E (TTM)

Icecure Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
5.54%-3.15M
40.49%-2.36M
2.89%-2.85M
12.39%-12.52M
44.89%-2.28M
-0.57%-3.34M
-4.91%-3.97M
4.02%-2.94M
-13.38%-14.29M
29.96%-4.13M
Net income from continuing operations
-3.73%-4.15M
20.78%-3.08M
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
Operating gains losses
-143.81%-46K
-60.00%36K
437.50%43K
-106.96%-25K
-93.22%-228K
223.53%105K
-82.00%90K
-87.10%8K
7,080.00%359K
-71.01%-118K
Depreciation and amortization
1.22%83K
3.80%82K
7.59%85K
30.24%323K
12.16%83K
17.14%82K
51.92%79K
51.92%79K
95.28%248K
80.49%74K
Other non cash items
----
----
----
----
----
---21K
----
----
----
----
Change In working capital
336.20%711K
300.45%443K
-1.03%384K
144.39%523K
129.97%193K
-43.01%163K
11.95%-221K
-52.86%388K
106.78%214K
76.73%-644K
-Change in receivables
1,750.00%185K
-772.00%-168K
16.92%-54K
-106.61%-25K
-95.76%5K
183.33%10K
-90.46%25K
-750.00%-65K
204.42%378K
131.98%118K
-Change in inventory
-111.43%-12K
-19.77%142K
330.99%164K
164.52%582K
333.33%371K
323.40%105K
154.13%177K
80.76%-71K
-1.23%-902K
12.15%-159K
-Change in prepaid assets
108.54%27K
-57.40%118K
-86.10%52K
-52.76%496K
125.04%161K
-177.83%-316K
-50.45%277K
-48.63%374K
151.72%1.05M
64.20%-643K
-Change in payables and accrued expense
16.14%554K
212.12%37K
637.93%156K
-26.95%-212K
-659.82%-627K
242.39%477K
-112.36%-33K
86.26%-29K
-170.76%-167K
166.67%112K
-Change in other current assets
19.64%67K
328.57%60K
56.25%75K
-25.71%182K
-21.95%64K
-17.65%56K
-78.79%14K
65.52%48K
140.36%245K
-29.31%82K
-Change in other current liabilities
34.91%-110K
137.30%254K
-106.87%-9K
-28.21%-500K
242.21%219K
-182.04%-169K
36.83%-681K
-79.40%131K
-178.63%-390K
73.45%-154K
Cash from discontinued investing activities
Operating cash flow
5.54%-3.15M
40.49%-2.36M
2.89%-2.85M
12.39%-12.52M
44.89%-2.28M
-0.57%-3.34M
-4.91%-3.97M
4.02%-2.94M
-13.38%-14.29M
29.96%-4.13M
Investing cash flow
Cash flow from continuing investing activities
-80.94%805K
-156.28%-843K
103.25%491K
19.98%-713K
418.26%8.69M
91.69%4.22M
132.38%1.5M
-10,400.00%-15.12M
-123.50%-891K
1,036.31%1.68M
Net PPE purchase and sale
58.44%-32K
91.67%-6K
88.80%-28K
46.13%-480K
19.00%-81K
74.16%-77K
79.37%-72K
-73.61%-250K
-67.17%-891K
43.82%-100K
Net investment purchase and sale
-80.53%837K
-153.31%-837K
103.56%529K
---529K
376.97%8.47M
71.93%4.3M
136.71%1.57M
---14.87M
--0
502.03%1.78M
Net other investing changes
--0
--0
---10K
--296K
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-80.94%805K
-156.28%-843K
103.25%491K
19.98%-713K
418.26%8.69M
91.69%4.22M
132.38%1.5M
-10,400.00%-15.12M
-123.50%-891K
1,036.31%1.68M
Financing cash flow
Cash flow from continuing financing activities
22,293.33%3.36M
1.89M
2.84M
-99.39%83K
-99.50%68K
15K
0
0
-56.05%13.58M
-16.40%13.58M
Net common stock issuance
--3.36M
--1.89M
--2.84M
--0
--0
--0
--0
--0
-55.57%13.58M
----
Proceeds from stock option exercised by employees
----
----
----
4,050.00%83K
6,700.00%68K
----
----
----
-99.41%2K
-99.70%1K
Cash from discontinued financing activities
Financing cash flow
22,293.33%3.36M
--1.89M
--2.84M
-99.39%83K
-99.50%68K
--15K
--0
--0
-56.05%13.58M
-16.40%13.58M
Net cash flow
Beginning cash position
218.44%9.65M
96.03%10.97M
-55.48%10.53M
-7.66%23.66M
-69.24%3.83M
-77.49%3.03M
-74.98%5.59M
-7.66%23.66M
631.61%25.62M
-19.16%12.44M
Current changes in cash
12.33%1.01M
46.79%-1.32M
102.64%476K
-718.87%-13.15M
-41.76%6.48M
180.65%900K
70.59%-2.47M
-463.58%-18.06M
-107.27%-1.61M
9.41%11.12M
Effect of exchange rate changes
107.62%8K
102.22%2K
-437.50%-43K
107.02%25K
132.65%228K
-223.53%-105K
81.13%-90K
87.10%-8K
-927.91%-356K
42.03%98K
End cash Position
178.91%10.67M
218.44%9.65M
96.03%10.97M
-55.48%10.53M
-55.48%10.53M
-69.24%3.83M
-77.49%3.03M
-74.98%5.59M
-7.66%23.66M
-7.66%23.66M
Free cash flow
6.73%-3.19M
41.40%-2.37M
9.63%-2.88M
14.37%-13M
44.28%-2.36M
5.58%-3.42M
2.20%-4.04M
0.53%-3.19M
-15.57%-15.18M
30.37%-4.23M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 5.54%-3.15M40.49%-2.36M2.89%-2.85M12.39%-12.52M44.89%-2.28M-0.57%-3.34M-4.91%-3.97M4.02%-2.94M-13.38%-14.29M29.96%-4.13M
Net income from continuing operations -3.73%-4.15M20.78%-3.08M4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M
Operating gains losses -143.81%-46K-60.00%36K437.50%43K-106.96%-25K-93.22%-228K223.53%105K-82.00%90K-87.10%8K7,080.00%359K-71.01%-118K
Depreciation and amortization 1.22%83K3.80%82K7.59%85K30.24%323K12.16%83K17.14%82K51.92%79K51.92%79K95.28%248K80.49%74K
Other non cash items -----------------------21K----------------
Change In working capital 336.20%711K300.45%443K-1.03%384K144.39%523K129.97%193K-43.01%163K11.95%-221K-52.86%388K106.78%214K76.73%-644K
-Change in receivables 1,750.00%185K-772.00%-168K16.92%-54K-106.61%-25K-95.76%5K183.33%10K-90.46%25K-750.00%-65K204.42%378K131.98%118K
-Change in inventory -111.43%-12K-19.77%142K330.99%164K164.52%582K333.33%371K323.40%105K154.13%177K80.76%-71K-1.23%-902K12.15%-159K
-Change in prepaid assets 108.54%27K-57.40%118K-86.10%52K-52.76%496K125.04%161K-177.83%-316K-50.45%277K-48.63%374K151.72%1.05M64.20%-643K
-Change in payables and accrued expense 16.14%554K212.12%37K637.93%156K-26.95%-212K-659.82%-627K242.39%477K-112.36%-33K86.26%-29K-170.76%-167K166.67%112K
-Change in other current assets 19.64%67K328.57%60K56.25%75K-25.71%182K-21.95%64K-17.65%56K-78.79%14K65.52%48K140.36%245K-29.31%82K
-Change in other current liabilities 34.91%-110K137.30%254K-106.87%-9K-28.21%-500K242.21%219K-182.04%-169K36.83%-681K-79.40%131K-178.63%-390K73.45%-154K
Cash from discontinued investing activities
Operating cash flow 5.54%-3.15M40.49%-2.36M2.89%-2.85M12.39%-12.52M44.89%-2.28M-0.57%-3.34M-4.91%-3.97M4.02%-2.94M-13.38%-14.29M29.96%-4.13M
Investing cash flow
Cash flow from continuing investing activities -80.94%805K-156.28%-843K103.25%491K19.98%-713K418.26%8.69M91.69%4.22M132.38%1.5M-10,400.00%-15.12M-123.50%-891K1,036.31%1.68M
Net PPE purchase and sale 58.44%-32K91.67%-6K88.80%-28K46.13%-480K19.00%-81K74.16%-77K79.37%-72K-73.61%-250K-67.17%-891K43.82%-100K
Net investment purchase and sale -80.53%837K-153.31%-837K103.56%529K---529K376.97%8.47M71.93%4.3M136.71%1.57M---14.87M--0502.03%1.78M
Net other investing changes --0--0---10K--296K------------------------
Cash from discontinued investing activities
Investing cash flow -80.94%805K-156.28%-843K103.25%491K19.98%-713K418.26%8.69M91.69%4.22M132.38%1.5M-10,400.00%-15.12M-123.50%-891K1,036.31%1.68M
Financing cash flow
Cash flow from continuing financing activities 22,293.33%3.36M1.89M2.84M-99.39%83K-99.50%68K15K00-56.05%13.58M-16.40%13.58M
Net common stock issuance --3.36M--1.89M--2.84M--0--0--0--0--0-55.57%13.58M----
Proceeds from stock option exercised by employees ------------4,050.00%83K6,700.00%68K-------------99.41%2K-99.70%1K
Cash from discontinued financing activities
Financing cash flow 22,293.33%3.36M--1.89M--2.84M-99.39%83K-99.50%68K--15K--0--0-56.05%13.58M-16.40%13.58M
Net cash flow
Beginning cash position 218.44%9.65M96.03%10.97M-55.48%10.53M-7.66%23.66M-69.24%3.83M-77.49%3.03M-74.98%5.59M-7.66%23.66M631.61%25.62M-19.16%12.44M
Current changes in cash 12.33%1.01M46.79%-1.32M102.64%476K-718.87%-13.15M-41.76%6.48M180.65%900K70.59%-2.47M-463.58%-18.06M-107.27%-1.61M9.41%11.12M
Effect of exchange rate changes 107.62%8K102.22%2K-437.50%-43K107.02%25K132.65%228K-223.53%-105K81.13%-90K87.10%-8K-927.91%-356K42.03%98K
End cash Position 178.91%10.67M218.44%9.65M96.03%10.97M-55.48%10.53M-55.48%10.53M-69.24%3.83M-77.49%3.03M-74.98%5.59M-7.66%23.66M-7.66%23.66M
Free cash flow 6.73%-3.19M41.40%-2.37M9.63%-2.88M14.37%-13M44.28%-2.36M5.58%-3.42M2.20%-4.04M0.53%-3.19M-15.57%-15.18M30.37%-4.23M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-1.06%